The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
Chloe Siu, PharmD, BCPS, BCOP
Advertisement
Articles by Chloe Siu, PharmD, BCPS, BCOP
This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Advertisement
Latest Updated Articles
Emerging Bispecific T-Cell Engagers in Myeloma: Promises and HurdlesPublished: April 7th 2025 | Updated:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapePublished: April 17th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
4
Addressing Drug Resistance in Lung Cancer
5
